A Roadmap for Future Parkinson's Pharmacogenomics in Asia.
作者信息
Akbar Muhammad, Soraya Gita Vita, Ulhaq Zulvikar Syambani, Bintang Andi Kurnia
机构信息
Department of Neurology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia.
Department of Biochemistry, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia.
出版信息
Front Aging Neurosci. 2022 May 17;14:896371. doi: 10.3389/fnagi.2022.896371. eCollection 2022.
Abstract
摘要
相似文献
1
A Roadmap for Future Parkinson's Pharmacogenomics in Asia.亚洲未来帕金森病药物基因组学路线图。
Front Aging Neurosci. 2022 May 17;14:896371. doi: 10.3389/fnagi.2022.896371. eCollection 2022.
2
The emerging science of precision medicine and pharmacogenomics for Parkinson's disease.帕金森病精准医学与药物基因组学的新兴科学。
Mov Disord. 2017 Aug;32(8):1139-1146. doi: 10.1002/mds.27099. Epub 2017 Jul 7.
3
A Systematic Review of Parkinson's Disease Pharmacogenomics: Is There Time for Translation into the Clinics?帕金森病药物基因组学的系统评价：是否有时间转化为临床应用？
Int J Mol Sci. 2021 Jul 5;22(13):7213. doi: 10.3390/ijms22137213.
4
How close are we to individualized medicine for Parkinson's disease?我们距离帕金森病的个性化医疗还有多远？
Expert Rev Neurother. 2016 Jul;16(7):815-30. doi: 10.1080/14737175.2016.1182021. Epub 2016 May 9.
5
Pharmacogenomics of Alzheimer's and Parkinson's diseases.阿尔茨海默病和帕金森病的药物基因组学。
Neurosci Lett. 2020 May 1;726:133807. doi: 10.1016/j.neulet.2018.09.018. Epub 2018 Sep 17.
6
Impact of gender and genetics on emotion processing in Parkinson's disease - A multimodal study.帕金森病中性别和遗传对情绪处理的影响 - 一项多模态研究。
Neuroimage Clin. 2018 Jan 31;18:305-314. doi: 10.1016/j.nicl.2018.01.034. eCollection 2018.
7
Parkinson's disease: piecing together a genetic jigsaw.帕金森病：拼凑基因拼图
Brain. 2003 Aug;126(Pt 8):1722-33. doi: 10.1093/brain/awg172. Epub 2003 May 21.
8
Iometopane: (123)I beta-CIT, dopascan injection, GPI 200, RTI 55.碘甲磺隆：（123）I β-CIT，多帕扫描注射液，GPI 200，RTI 55。
Drugs R D. 2003;4(5):320-2. doi: 10.2165/00126839-200304050-00008.
9
Pharmacogenomics and treatment for dementia induced by Alzheimer's disease.药物基因组学与阿尔茨海默病所致痴呆的治疗
Pharmacogenomics. 2008 Jul;9(7):895-903. doi: 10.2217/14622416.9.7.895.
10
Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism.帕金森病中多巴胺D2受体的基因多态性及其与吸烟和单胺氧化酶B基因内含子13多态性的相互作用
J Neurol Neurosurg Psychiatry. 2000 Oct;69(4):535-7. doi: 10.1136/jnnp.69.4.535.
本文引用的文献
1
Polymorphisms of the dopamine metabolic and signaling pathways are associated with susceptibility to motor levodopa-induced complications (MLIC) in Parkinson's disease: a systematic review and meta-analysis.多巴胺代谢和信号通路的多态性与帕金森病运动性左旋多巴诱导并发症（MLIC）的易感性有关：系统评价和荟萃分析。
Neurol Sci. 2022 Jun;43(6):3649-3670. doi: 10.1007/s10072-021-05829-4. Epub 2022 Jan 25.
2
Genetic variants in levodopa-induced dyskinesia (LID): A systematic review and meta-analysis.左旋多巴诱导的异动症（LID）中的基因变异：一项系统评价和荟萃分析。
Parkinsonism Relat Disord. 2021 Mar;84:52-60. doi: 10.1016/j.parkreldis.2021.01.020. Epub 2021 Jan 31.
3
Young Onset Parkinson's Disease: A Modern and Tailored Approach.早发型帕金森病：一种现代且个性化的治疗方法。
J Parkinsons Dis. 2020;10(s1):S29-S36. doi: 10.3233/JPD-202135.
4
Southeast Asian Pharmacogenomics Research Network (SEAPharm): Current Status and Perspectives.东南亚药物基因组学研究网络（SEAPharm）：现状与展望
Public Health Genomics. 2019;22(3-4):132-139. doi: 10.1159/000502916. Epub 2019 Oct 4.
5
Influence of DRD1 and DRD3 Polymorphisms in the Occurrence of Motor Effects in Patients with Sporadic Parkinson's Disease.DRD1 和 DRD3 多态性对散发性帕金森病患者运动效应发生的影响。
Neuromolecular Med. 2019 Sep;21(3):295-302. doi: 10.1007/s12017-019-08549-3. Epub 2019 May 22.
6
Long-term outcomes of deep brain stimulation in Parkinson disease.帕金森病深部脑刺激的长期疗效。
Nat Rev Neurol. 2019 Apr;15(4):234-242. doi: 10.1038/s41582-019-0145-9.
7
Pharmacogenetics and levodopa induced motor complications.药物遗传学与左旋多巴诱发的运动并发症
Int J Neurosci. 2019 Apr;129(4):384-392. doi: 10.1080/00207454.2018.1538993. Epub 2018 Dec 2.
8
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts.左旋多巴诱导的帕金森病运动障碍：当前和不断发展的概念。
Ann Neurol. 2018 Dec;84(6):797-811. doi: 10.1002/ana.25364. Epub 2018 Nov 30.
9
DAT gene polymorphisms (rs28363170, rs393795) and levodopa-induced dyskinesias in Parkinson's disease.帕金森病中 DAT 基因多态性（rs28363170，rs393795）与左旋多巴诱导的异动症
Neurosci Lett. 2019 Jan 18;690:83-88. doi: 10.1016/j.neulet.2018.10.021. Epub 2018 Oct 11.
10
Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、地区和国家帕金森病负担，1990-2016 年：2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2018 Nov;17(11):939-953. doi: 10.1016/S1474-4422(18)30295-3. Epub 2018 Oct 1.
Zotero 插件